| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature Review
|
Zhang, Bo
|
|
2018
|
13 |
5 |
p. 631-639
|
artikel
|
| 2 |
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer
|
Iacovelli, Roberto
|
|
2018
|
13 |
5 |
p. 649-655
|
artikel
|
| 3 |
Correction to: Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease
|
Hochmair, Maximilian
|
|
2018
|
13 |
5 |
p. 667
|
artikel
|
| 4 |
EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)
|
Ruiz-Patiño, Alejandro
|
|
2018
|
13 |
5 |
p. 621-629
|
artikel
|
| 5 |
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane
|
Willemsen, Annelieke E. C. A. B.
|
|
2018
|
13 |
5 |
p. 641-648
|
artikel
|
| 6 |
Immediate Progressive Disease in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab: a Multi-Institution Retrospective Study
|
Ishihara, Hiroki
|
|
2018
|
13 |
5 |
p. 611-619
|
artikel
|
| 7 |
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
|
Tzeng, Alice
|
|
2018
|
13 |
5 |
p. 599-609
|
artikel
|
| 8 |
Targeted Therapies in the Treatment of Sarcomas
|
Hoffner, Brianna
|
|
2018
|
13 |
5 |
p. 557-565
|
artikel
|
| 9 |
Targeting Toll-Like Receptors for Cancer Therapy
|
Braunstein, Marc J.
|
|
2018
|
13 |
5 |
p. 583-598
|
artikel
|
| 10 |
Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches
|
Femia, Daniela
|
|
2018
|
13 |
5 |
p. 567-582
|
artikel
|
| 11 |
TRK Inhibition: A New Tumor-Agnostic Treatment Strategy
|
Kummar, Shivaani
|
|
2018
|
13 |
5 |
p. 545-556
|
artikel
|
| 12 |
Tumor Type-Agnostic Treatment and the Future of Cancer Therapy
|
Raez, Luis E.
|
|
2018
|
13 |
5 |
p. 541-544
|
artikel
|
| 13 |
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells
|
Mortara, Lorenzo
|
|
2018
|
13 |
5 |
p. 657-665
|
artikel
|
Tijdschrift beschrijving